VeraDermics IPO: Hair-Loss Drug Developer Targets $200M+ U.S. Listing
U.S.-based biopharmaceutical company VeraDermics Inc. is preparing to enter the public markets with an initial public offering that…
Aptus Pharma IPO Explain & GMP Status
Aptus Pharma IPO Overview Aptus Pharma Limited IPO opens on September 23, 2025, and closes on September 25,…



































































